Metraipolis › archive › dc_cd31ab9fcef2
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:42568726
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42568726
- DOI
- 10.1016/j.esmorw.2025.100646
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T16:31:47.363Z
- SHA-256 of the archived text
9158e84b72c46d9a9a843f0bc82927f466d7641355b9b551cea91ce8459abbfa- Stable URL of this page
https://metraipolis.com/documento/dc_cd31ab9fcef2
How to cite
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:42568726 — Europe PMC (en), https://europepmc.org/article/MED/42568726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd31ab9fcef2 (Metraipolis archive dc_cd31ab9fcef2, sha256 9158e84b72c46d9a9a843f0bc82927f466d7641355b9b551cea91ce8459abbfa)
BibTeX
@misc{dccd31ab9fcef2,
title = {JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan — Europe PMC PMID:42568726},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42568726},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd31ab9fcef2; sha256 9158e84b72c46d9a9a843f0bc82927f466d7641355b9b551cea91ce8459abbfa},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42568726. Agents can read the archived copy with the MCP tool read_document.